Literature DB >> 24954556

Effects of overshadowing on conditioned and unconditioned nausea in a rotation paradigm with humans.

Ursula Stockhorst1, Geoffrey Hall, Paul Enck, Sibylle Klosterhalfen.   

Abstract

We examine whether overshadowing by salient stimuli is effective in reducing the ability of a certain environment (the putative conditioned stimulus) to evoke conditioned nausea in healthy humans that experience nausea-evoking rotation (as the unconditioned stimulus, US) in that environment. Twenty-four rotation-susceptible subjects (12 males, 12 females) were randomly assigned to receive either overshadowing by salient tasting beverages (OS+), or a control treatment (a familiar beverage, water; OS-) prior to rotation on three consecutive days (acquisition). To control for taste experiences, the alternative beverage was consumed 12 h later in the home environment (OS+: water, OS-: salient beverage). At Day 4 (test), all subjects drank the familiar beverage (water) prior to rotation (US). Rotation was standardized as 2 × 1-min rotation/day. Nausea was determined by a 7-item symptom scale measuring symptom number (SN) prior to (anticipatory), immediately after, and 15 and 30 min after rotation and by the Nausea Profile (NP) questionnaire immediately after rotation. Cortisol and tumour necrosis factor (TNF)-α in saliva were sampled at the same time-points. SN and cortisol were also measured at home. Overshadowing reduced anticipatory (conditioned) SN. Post-rotation nausea (i.e. the unconditioned response) measured by the NP decreased within the OS+ group only. Anticipatory cortisol and TNF-α were not affected by overshadowing. Treatment × gender interactions manifested for post-rotation cortisol and TNF-α. Groups did not differ in SN and cortisol at home. Overshadowing is effective in reducing symptoms of anticipatory nausea and rotation-induced unconditioned nausea; its effect on endocrine and immunological parameters is gender specific. Its application in alleviation of anticipatory nausea in cancer patients is considered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24954556     DOI: 10.1007/s00221-014-3998-6

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  36 in total

Review 1.  Physiological basis and pharmacology of motion sickness: an update.

Authors:  B J Yates; A D Miller; J B Lucot
Journal:  Brain Res Bull       Date:  1998-11-15       Impact factor: 4.077

2.  Interfering with taste aversion learning in rats: the role of associative interference.

Authors:  D S Cannon; M R Best; J D Batson; E R Brown; J A Rubenstein; L E Carrell
Journal:  Appetite       Date:  1985-03       Impact factor: 3.868

Review 3.  Anticipatory nausea and vomiting.

Authors:  Matti S Aapro; Alexander Molassiotis; Ian Olver
Journal:  Support Care Cancer       Date:  2004-12-15       Impact factor: 3.603

4.  Sexual dimorphism in the pituitary-adrenal response to tumor necrosis factor-alpha, but not to interleukin-6, in the rat.

Authors:  Hajime Watanobe
Journal:  Brain Res Bull       Date:  2002-01-15       Impact factor: 4.077

Review 5.  Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).

Authors:  G R Morrow; J T Hickok; S N Rosenthal
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

Review 6.  Anticipatory nausea and vomiting due to chemotherapy.

Authors:  Charles Kamen; Mohamedtaki A Tejani; Kavita Chandwani; Michelle Janelsins; Anita R Peoples; Joseph A Roscoe; Gary R Morrow
Journal:  Eur J Pharmacol       Date:  2013-10-21       Impact factor: 4.432

7.  Assessment of the multiple dimensions of nausea: the Nausea Profile (NP).

Authors:  E R Muth; R M Stern; J F Thayer; K L Koch
Journal:  J Psychosom Res       Date:  1996-05       Impact factor: 3.006

8.  Effects of overshadowing on conditioned nausea in cancer patients: an experimental study.

Authors:  U Stockhorst; J A Wiener; S Klosterhalfen; W Klosterhalfen; C Aul; H J Steingrüber
Journal:  Physiol Behav       Date:  1998-07

9.  Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats.

Authors:  Mohamed A Zeidan; Sarah A Igoe; Clas Linnman; Antonia Vitalo; John B Levine; Anne Klibanski; Jill M Goldstein; Mohammed R Milad
Journal:  Biol Psychiatry       Date:  2011-07-18       Impact factor: 13.382

10.  The incidence of anticipatory nausea and vomiting after repeat cycle chemotherapy: the effect of granisetron.

Authors:  M S Aapro; V Kirchner; J P Terrey
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

View more
  3 in total

Review 1.  Antihistamines for motion sickness.

Authors:  Nadine Karrim; Ryan Byrne; Nombulelo Magula; Yougan Saman
Journal:  Cochrane Database Syst Rev       Date:  2022-10-17

2.  2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy.

Authors:  L Lee Dupuis; Joseph A Roscoe; Ian Olver; Matti Aapro; Alexander Molassiotis
Journal:  Support Care Cancer       Date:  2016-08-10       Impact factor: 3.603

3.  Sex and Age Differences in Motion Sickness in Rats: The Correlation with Blood Hormone Responses and Neuronal Activation in the Vestibular and Autonomic Nuclei.

Authors:  Wei Zhou; Junqin Wang; Leilei Pan; Ruirui Qi; Peng Liu; Jiluo Liu; Yiling Cai
Journal:  Front Aging Neurosci       Date:  2017-02-15       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.